August 12, 2011
By Shelley Jazowski
In a recent post, I commented on the safety of generic medications specific to product labeling. Safety concerns are not singular to generics, but pervade the drug development, manufacturing and marketing components of the overall prescription drug industry. Below, I outline three primary concerns and comment on their proposed solutions.